Eton Pharmaceuticals Inc. (ETON)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
14.08
0.66 (4.92%)
At close: Jan 15, 2025, 2:51 PM
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
Cash & Equivalents | 21.39M | 16.30M | 14.41M | 21.30M | 12.07M | 26.73M | 13.16M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 12.00K | 12.00K | 21.00K | 40.00K | 61.00K | 52.00K | 32.00K |
Receivables | 3.41M | 1.85M | 5.47M | 48.00K | 473.00K | n/a | n/a |
Inventory | 911.00K | 557.00K | 550.00K | 1.24M | 380.00K | n/a | n/a |
Other Current Assets | 1.13M | 1.29M | 6.35M | 4.23M | 3.18M | 767.00K | 136.00K |
Total Current Assets | 26.84M | 20.00M | 23.60M | 24.70M | 15.01M | 27.50M | 13.29M |
Property-Plant & Equipment | 150.00K | 260.00K | 219.00K | 1.00M | 1.28M | 773.00K | 119.00K |
Goodwill & Intangibles | 4.74M | 4.75M | 3.62M | 575.00K | 725.00K | n/a | n/a |
Total Long-Term Assets | 4.90M | 5.03M | 3.86M | 1.62M | 2.06M | 825.00K | 151.00K |
Total Assets | 31.74M | 25.03M | 27.46M | 26.32M | 17.07M | 28.33M | 13.44M |
Account Payables | 1.85M | 1.77M | 1.77M | 2.34M | 575.00K | 1.42M | 539.00K |
Deferred Revenue | n/a | n/a | n/a | n/a | -133.00K | n/a | n/a |
Short-Term Debt | 5.38M | 1.03M | 1.42M | 280.00K | n/a | n/a | n/a |
Other Current Liabilities | 9.01M | 3.66M | 1.37M | 1.17M | 1.39M | 603.00K | 254.00K |
Total Current Liabilities | 16.24M | 6.46M | 4.56M | 3.79M | 1.96M | 2.02M | 793.00K |
Long-Term Debt | 22.00K | 5.49M | 5.28M | 6.86M | 4.56M | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | 520.00K |
Total Long-Term Liabilities | 22.00K | 5.49M | 5.28M | 6.86M | 4.56M | 1.42M | 520.00K |
Total Liabilities | 16.26M | 11.95M | 9.84M | 10.66M | 6.52M | 2.02M | 1.31M |
Total Debt | 5.40M | 6.52M | 6.70M | 7.14M | 4.56M | n/a | n/a |
Common Stock | 26.00K | 25.00K | 25.00K | 24.00K | 18.00K | 18.00K | 6.00K |
Retained Earnings | -104.07M | -103.13M | -94.11M | -92.16M | -64.19M | -45.87M | -8.64M |
Comprehensive Income | n/a | n/a | n/a | n/a | n/a | -0.00 | -19.00M |
Shareholders Equity | 15.48M | 13.08M | 17.63M | 15.66M | 10.55M | 26.30M | 12.13M |
Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a |